Dr Binith Cheeran was appointed as a Senior Clinical Fellow in the University of Oxford in 2013. He completed his PhD at the Sobell Department of Movement Disorders and Motor Neurophysiology at the Institute of Neurology, London and thereafter joined the Oxford Deanery Neurology Specialist Training Program in 2008. As a consultant neurologist, Dr Cheeran specializes in Parkinson’s Disease and other Movement Disorders, working closely with the functional neurosurgery team at the John Radcliffe Hospital, Oxford.
Honorary Consultant Neurologist
Transcranial Magnetic Stimulation (TMS) technology allows neuroscientists to non-invasively study brain function, and motor control in particular, with a high degree of temporal and spatial specificity. Moreover, as several TMS paradigms can modulate underlying cortical activity, there is considerable interest in employing these paradigms as part of therapeutic or restorative therapy. Dr Cheeran’s research has been focussed on improving our understanding of these valuable research tools and applications in the field of Parkinson’s Disease.
Awards Training and Qualifications
- CCST Neurology (Oxford Deanery) (2012)
- PhD (University College London) (2011)
- The Queen Square Prize in Neurology (Institute of Neurology, London) (2008)
- The Movement Disorders Society Young Investigator Prize (Basic Science) (Movement Disorders Society) (2008)
- Wellington Fund PhD Studentship (2005-2008)
- Membership of the Royal College Of Physicians (UK) (2004)
- M.B., B.S. (Kasturba Medical College, India) (2001)
- Nuffield Oxford Hospitals Fund
- DeNDRoN (Thames Valley Dementias & Neurodegenerative Diseases Research Network)
- NIHR RCF Oxfordshire Health Services Research Committee (OHSRC)
- Parkinson’s UK
Inter-individual variability in response to non-invasive brain stimulation paradigms.
López-Alonso V. et al, (2014), Brain Stimul, 7, 372 - 380
Further insights into the effect of BDNF genotype on non-invasive brain stimulation.
Suppa A. and Cheeran B., (2015), Clin Neurophysiol, 126, 1281 - 1283
A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS.
Cheeran B. et al, (2008), J Physiol, 586, 5717 - 5725
Theta burst stimulation in the rehabilitation of the upper limb: a semirandomized, placebo-controlled trial in chronic stroke patients.
Talelli P. et al, (2012), Neurorehabil Neural Repair, 26, 976 - 987
Distinct mechanisms mediate speed-accuracy adjustments in cortico-subthalamic networks.
Herz DM. et al, (2017), Elife, 6
Stimulating at the right time: phase-specific deep brain stimulation.
Cagnan H. et al, (2017), Brain, 140, 132 - 145
Adaptive deep brain stimulation for Parkinson's disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting.
Little S. et al, (2016), J Neurol Neurosurg Psychiatry, 87, 1388 - 1389
Post-Traumatic Tremor and Thalamic Deep Brain Stimulation: Evidence for Use of Diffusion Tensor Imaging.
Boccard SG. et al, (2016), World Neurosurg, 96, 607.e7 - 607.e11
Paradoxical facilitation after depotentiation protocol can precede dyskinesia onset in early Parkinson's disease.
Lago-Rodriguez A. et al, (2016), Exp Brain Res, 234, 3659 - 3667